| Randomized, four-way, four-period, single oral dose, open-label, crossover, bioequivalence study to compare Tacrolimus Immediate-release capsules (5 mg tacrolimus) versus Prograf® Immediate-release capsules (5 mg tacrolimus), in healthy subjects under fasting conditions. |
Ongoing |
Tacrolimus/ Prograf |
1, BE |
19-2017 |
Saudi Ajal |
| Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma |
Ongoing |
Sorafenib (Nexavar) |
3 |
RTOG 1112 |
KFSH & RC-R |
| "Randomized clinical trial of neoadjuvant chemotherapy with denosumab compared to chemotherapy alone in hormonal receptor-positive, HER2-negative premenopausal breast cancer patients" |
Ongoing |
DENOSUMAB |
3 |
20-610 |
King Abdullah Medical City (Makkah) |
| "randomised, multicentre, double-blind, placebo-controlled study of ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH)" |
Completed |
Ambrisentan 5 mg |
3 |
AMB115811 |
KFMC |
| RAINBOW study: a randomized, controlled study evaluating the efficacy and safety of Ranibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity |
Ongoing |
Ranibizumab |
3 |
CRFB002H2301 V 01 |
KFSH & RC-R |
| "PROSPECTIVE, RANDOMIZED, OPEN LABEL CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF DEXMEDETOMIDINE USE BEYOND 24 HOURS COMPARED WITH MIDAZOLAM IN CHILDREN ADMITTED TO PEDIATRIC INTENSIVE CARE UNIT (PICU) AT KASCH-MNGHA. (PROMISE)" |
Rejected |
Dexmedetomidine (Hospira) |
3 |
RC20/160/R |
King Abdulaziz Medical City NG (Riyadh) |
| Prospective, Randomized, Open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine Compared with Midazolam in children admitted to Pediatric Intensive Care unit (PICU) at KAMC-NGHA |
Rejected |
Dexmedetomidine (Precedex) |
3 |
RC11/084/R |
NGHA-R |
| Prospective, Randomized, open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine Compared with Midazolam in children admitted to Pediatric Critical Care unit (PICU) at KAMC-NGHA (PROMISE) |
Rejected |
Dexmedetomidine |
3 |
RC11/084 |
NGHA-R |
| Prospective, Open-label, Uncontrolled, Phase III Study to Assess the Efficacy and Safety of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery in Subjects With Congenital Fibrinogen Deficiency |
Ongoing |
Octafibrin |
3 |
Forma 02 |
KKUH |
| Prophylactic Acetaminophen (Panadol) To Prevent the Intraventricular Haemorrhage of Premature Babies. |
Rejected |
Acetaminophen |
3 |
HRC-09-Nov15-02 |
KSMC |
